Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Leiomyoma 3Neoplasms 2Stroke 1Sarcoma, Alveolar Soft Part 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Peripheral Nervous System Diseases 1Neuralgia 1Myocardial Infarction 1Liver Neoplasms 1Liver Cirrhosis 1Hot Flashes 1Hemorrhage 1Hand-Foot Syndrome 1Colorectal Neoplasms 1Cardiovascular Diseases 1Carcinoma, Hepatocellular 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

Nutrition Assessment 3Transcranial Direct Current Stimulation 2urinastatin 1tocilizumab 1rimabotulinumtoxinB 1X-Rays 1Vitamin B 6 1Vitamin B 12 1Thrombectomy 1Standard of Care 1Saline Solution 1Rosuvastatin Calcium 1Resistance Training 1Practice Guidelines as Topic 1Phenylephrine 1Palliative Care 1Norepinephrine 1Music Therapy 1Massage 1Lysine Acetyltransferase 5 1Infliximab 1Immunoglobulin G 1Folic Acid 1Extracorporeal Shockwave Therapy 1Exergaming 1Enoxaparin 1Disulfides 1Dialectical Behavior Therapy 1Cholecalciferol 1Cerebral Angiography 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Stroke × Vitamin B 6 × Clear all
NCT00106886 2005-09-20

HOPE-2 Study (Heart Outcomes Prevention Evaluation-2 Study)

McMaster University

Phase 4 Unknown
5,000 enrolled

Cardiovascular Diseases, Myocardial Infarction, Neoplasms, Stroke

Data powered by HemOnc (CC BY 4.0) Colophon âš¡